GFAP and central nervous system cancer: In the present study, we constructed and evaluated the potential functional and therapeutic effectiveness of a recombinant adenovirus Ad-GFAP-hNIS carrying the hNIS gene controlled by the GFAP promoter in U251 and U87 glioma cell lines.